BioCentury
ARTICLE | Financial News

eGenesis completes venture financing

March 17, 2017 7:11 PM UTC

On March 16, xenotransplantation company eGenesis Inc. (Boston, Mass.) raised the undisclosed first tranche of a planned $38 million series A round co-led by Biomatics Capital Partners and Arch Ventur...